Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review

2011 ◽  
Vol 19 (6) ◽  
pp. 1818-1824 ◽  
Author(s):  
Marie Catherine Lee ◽  
Robert Plews ◽  
Bhupendra Rawal ◽  
John V. Kiluk ◽  
Loretta Loftus ◽  
...  
2011 ◽  
Vol 29 (27_suppl) ◽  
pp. 4-4
Author(s):  
B. Lee ◽  
A. Lim ◽  
J. Krell ◽  
K. Satchithananda ◽  
J. S. Lewis ◽  
...  

4 Background: Recent reports have indicated a lack of overall survival benefit for axillary node dissection versus sentinel lymph node biopsy in early breast cancer. To study this further, we wished to assess the accuracy and effectiveness of ultrasound guided fine needle aspiration (FNA) cytology in detecting lymph node involvement in breast cancer patients, in order to refine and evaluate our current clinical pathways as newly diagnosed invasive breast cancer patients routinely undergo pre-surgical axillary ultrasound. Methods: An FNA was taken from nodes of consecutive patients, which appeared abnormal on ultrasonography based on size, morphology, fatty hilum and cortical thickness measurements. Ultrasound and FNA cytological findings were correlated with histology following axillary node dissection. Of 260 cases, 123 (47.3%) had metastatic nodal involvement. Of these cases, only 66 (53.7%) were reported as positive on US findings. Results: The overall positive predictive value (PPV) of ultrasound for detecting metastatic nodal involvement measured 0.82, and the negative predictive value (NPV) was 0.60. The sensitivity was 0.54, specificity measured 0.85 and the accuracy was 0.68. The ultrasound morphological nodal features with the greatest correlation with malignancy were absence of a fatty hilum (p=0.003) and an increased cortical thickness (p=0.03). Cases with a metastatic nodal burden density of a least 20% were also more likely to be detected as abnormal on axillary ultrasound. (p=0.009). Conclusions: Axillary ultrasound has a low NPV and negative sonographic results do not exclude node metastases with sufficient sensitivity in most cases, to justify its routine clinical use. [Table: see text]


2006 ◽  
Vol 9 (5) ◽  
pp. 1-3
Author(s):  
S. Masood

Determining whether cancer has spread to the lymph nodes is important in predicting survival from breast cancer and determining what treatment a patient requires. The traditional method of detecting such metastases, complete axillary node dissection, can result in lymphedema and other quality-of-life damaging side effects. The new technique of sentinel lymph node biopsy (SLNB) offers a way to test for lymph node metastases without causing the side effects of traditional axillary node dissection. Intraoperative analysis of SLNB is becoming an effective tool in assessment of the presence or absence of metastatic tumor, and therefore influences the treatment offered to the patient. Because of this central diagnostic use, as it is a new procedure, further studies need to be conducted to fully assess its role in breast cancer treatment.


2004 ◽  
Vol 29 (11) ◽  
pp. 698-702 ◽  
Author(s):  
Aswani Sood ◽  
Irini M. Youssef ◽  
Sherif I. Heiba ◽  
Hossam El-Zeftawy ◽  
Deborah Axelrod ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document